Cellevate
Lund · Founded 2014 · $8.5M raised
- Headquarters
- Lund
- Founded
- 2014
- Business Model
- B2B
- Website
- cellevate.com
- Total Funding
- $8.5M
- Last Round
- $1.9M Venture RoundMar 2026
- Rounds
- 3
About
Cellevate AB is a Swedish biotech company headquartered at Medicon Village in Lund that develops Cellevat3d, a nanofiber-based microcarrier technology for 3D cell culture. Originating from a collaborative research project with Lund University's Solid-State Physics department, its microcarriers support cell and gene therapy, vaccine, and viral-vector (AAV and lentivirus) production, aiming to improve the manufacturing of biological drugs.
Summary
Cellevate is a Biotech company based in Lund, founded in 2014. It has raised $8.5M in total across 3 rounds, most recently a $1.9M Venture Round round in Mar 2026. Investors include Industrifonden, European Innovation Council Fund and Almi Invest.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...